238 related articles for article (PubMed ID: 12200630)
1. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
2. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
[TBL] [Abstract][Full Text] [Related]
3. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B).
Englund C; Folkerth RD; Born D; Lacy JM; Hevner RF
Acta Neuropathol; 2005 May; 109(5):519-33. PubMed ID: 15877232
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
5. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
[TBL] [Abstract][Full Text] [Related]
6. Cortical neuronal densities and lamination in focal cortical dysplasia.
Thom M; Martinian L; Sen A; Cross JH; Harding BN; Sisodiya SM
Acta Neuropathol; 2005 Oct; 110(4):383-92. PubMed ID: 16151726
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
8. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
[TBL] [Abstract][Full Text] [Related]
10. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
[TBL] [Abstract][Full Text] [Related]
11. CD34-immunoreactive balloon cells in cortical malformations.
Fauser S; Becker A; Schulze-Bonhage A; Hildebrandt M; Tuxhorn I; Pannek HW; Lahl R; Schramm J; Blümcke I
Acta Neuropathol; 2004 Oct; 108(4):272-8. PubMed ID: 15221338
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
13. Mcm2 labelling of balloon cells in focal cortical dysplasia.
Thom M; Martinian L; Sisodiya SM; Cross JH; Williams G; Stoeber K; Harkness W; Harding BN
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):580-8. PubMed ID: 16281906
[TBL] [Abstract][Full Text] [Related]
14. Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development.
Aronica E; Ozbas-Gerçeker F; Redeker S; Ramkema M; Spliet WG; van Rijen PC; Leenstra S; Gorter JA; Troost D
Acta Neuropathol; 2004 Nov; 108(5):422-34. PubMed ID: 15375667
[TBL] [Abstract][Full Text] [Related]
15. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
Miyata H; Chiang AC; Vinters HV
Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
[TBL] [Abstract][Full Text] [Related]
16. Differential expression patterns of chloride transporters, Na+-K+-2Cl--cotransporter and K+-Cl--cotransporter, in epilepsy-associated malformations of cortical development.
Aronica E; Boer K; Redeker S; Spliet WG; van Rijen PC; Troost D; Gorter JA
Neuroscience; 2007 Mar; 145(1):185-96. PubMed ID: 17207578
[TBL] [Abstract][Full Text] [Related]
17. Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis.
Thom M; Harding BN; Lin WR; Martinian L; Cross H; Sisodiya SM
Acta Neuropathol; 2003 Jun; 105(6):561-9. PubMed ID: 12734663
[TBL] [Abstract][Full Text] [Related]
18. Transcription of intermediate filament genes is enhanced in focal cortical dysplasia.
Taylor JP; Sater R; French J; Baltuch G; Crino PB
Acta Neuropathol; 2001 Aug; 102(2):141-8. PubMed ID: 11563628
[TBL] [Abstract][Full Text] [Related]
19. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
[TBL] [Abstract][Full Text] [Related]
20. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
